SightfileU.S. market data from official filings

SS INNOVATIONS INTERNATIONAL COM NEW (SSII)

Name: SS INNOVATIONS INTERNATIONAL COM NEW (SSII) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001676163 · EDGAR filings · Updated 2026-07-17

SS INNOVATIONS INTERNATIONAL COM NEW (SSII) has reported institutional ownership of 0.8%, with 25 institutional managers holding positions valued at $8.39M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

0.8%

Institutional managers

Reported 13F value

$8.39M

Insider activity

48 trans.

$5.25M net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-17 — Current report (8-K) filed
2026-07-14 — Current report (8-K) filed
2026-07-07 — Current report (8-K) filed
2026-06-30 — Current report (8-K) filed
2026-06-18 — Current report (8-K) filed
2026-06-18 — Prospectus supplement (424B5) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SS INNOVATIONS INTERNATIONAL COM NEW has 25 institutional holders and institutional ownership of 0.8%.

Insider activity

Insiders reported 48 transactions (20 buys, 0 sells) across 9 reporting insiders, with a net reported value of $5.25M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-13 (recurring since 2022-02-22) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2024-08-14 (recurring since 2024-08-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

TVARDI THERAPEUTICS INC COM (TVRD) · RENOVORX INC (RNXT) · Bausch Lomb Corp (BLCO) · VISTAGEN THERAPEUTICS INC (VTGN) · TherapeuticsMD Inc (TXMD) · VYNE THERAPEUTICS INC (VYNE)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.